![AbbVie Header](https://www.pharmacompass.com/image/flap/abbvie-header-w29-desktop-header-1gif-4289.gif)
![AbbVie Header](https://www.pharmacompass.com/image/flap/abbvie-header-w29-mobgif-81230.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.shieldtherapeutics.com/shield-provides-full-year-trading-update-and-reports-progress-on-the-commercialization-of-accrufer-feraccru/
https://www.globenewswire.com/news-release/2021/06/21/2250261/0/en/Shield-Therapeutics-PLC-Shield-to-Webcast-Live-at-Life-Sciences-Investor-Forum-June-24th.html
https://www.sharesmagazine.co.uk/news/market/6737889/China-licence-agreement-for-Feraccru-Accrufer
https://www.sharesmagazine.co.uk/news/market/6737889/China-licence-agreement-for-Feraccru-Accrufer
https://www.sharesmagazine.co.uk/news/market/6737889/China-licence-agreement-for-Feraccru-Accrufer
https://simplywall.st/stocks/gb/pharmaceuticals-biotech/aim-stx/shield-therapeutics-shares/news/what-investors-should-know-about-shield-therapeutics-plcs-lonstx-financial-strength/
http://www.biospace.com/News/in-need-of-cash-uks-shield-therapeutics-could/408805/source=TopBreaking